Page last updated: 2024-10-29

imipramine and Chromosome-Defective Micronuclei

imipramine has been researched along with Chromosome-Defective Micronuclei in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sołek, P1
Mytych, J1
Tabęcka-Łonczyńska, A1
Koziorowski, M1
Madrigal-Bujaidar, E1
Madrigal-Santillán, EO1
Alvarez-Gonzalez, I1
Baez, R1
Marquez, P1

Other Studies

2 other studies available for imipramine and Chromosome-Defective Micronuclei

ArticleYear
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
    International journal of molecular sciences, 2021, Nov-01, Volume: 22, Issue:21

    Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxe

2021
Micronuclei induced by imipramine and desipramine in mice: a subchronic study.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 103, Issue:6

    Topics: Animals; Antidepressive Agents, Tricyclic; Bone Marrow Cells; Desipramine; Imipramine; Male; Mice; M

2008